Expanding Pharmaceutical Cold Chain Packaging Market Forecasted to Surpass US$ 60,100.9 million by 2033.

By 2022, the global pharmaceutical cold chain packaging market size was worth US$ 13,413 million growing from US$ 6,249.2 million in 2016. Over these years between 2016 and 2022 the market followed an average CAGR of 13.3% withstanding the pandemic lockdown and business disruptions.

In the present year 2023, the net valuation of total demand for pharmaceutical cold chain packaging requirements is likely to be around US$ 15,176.2 million. Further, as per the pharmaceutical cold chain packaging market analysis report, it could progress at a higher compound annual growth rate of 14.8% through 2033. Consequently, the overall valuation of the market is projected to reach US$ 60,100.9 million by the end of this forecast period.

The need for pharmaceutical cold chain packaging facilities has expanded recently due to the introduction of more complicated biologically based medications. Furthermore, increased shipments of vaccinations, hormone therapies, and intricate proteins that need cold chain packaging to be traded at a regulated temperature have also rendered the business rewarding.

For More Insights on this Market, Get A Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13956

Unfortunately, the adoption of pharmaceutical cold chain packaging services is anticipated to be constrained by the high cost and some government regulations.

Key Takeaways

• The United States pharmaceutical cold chain packaging market generated a revenue of around US$ 2,494.5 million in the year 2022. This revenue share was around 18.6% of the global revenue making the United States the top region for the market.
• In Europe, Germany is the leading provider of pharmaceutical cold chain packaging services and contributes 3.8% to the global market share.
• In the Asia Pacific region, China tops in sales of pharmaceutical cold chain packaging services and other requirements for both domestic and adjacent markets. The net valuation of this regional market in 2022 was US$ 1,503.7 million and it is also progressing at a 17.7% growth rate.

Competitive Landscape for the Pharmaceutical Cold Chain Packaging Market Players

Sonoco ThermoSafe, Cold Chain Technologies, Sealed Air Corporation, Nordic Cold Chain Solutions, Cryopak, CSafe Global LLC, TemperPack Technologies, Inc., Insulated Product Corp., Global Cooling, Inc., Envirotainer AB, va-Q-tec AG, EMBALL’ISO, Softbox Systems, Sofrigam SAS, DGP Intelsius LLC, Tempack Packaging Solutions SL, TOWER Cold Chain Solutions, Pelican BioThermal LLC, Blue Star Limited, BIOBASE Group, Andores New Energy Co., Ltd., Haier Biomedical Co. Ltd., Tamai Kasei Co., Ltd., Dhruvraj Syndicate, Valor Industries, KODIAKOOLER, WoolCool Ltd., and Allwin Roto Plast among others are some prominent players in the global pharmaceutical cold chain packaging market.

Customize your report by selecting specific countries or regions and save 30% @ https://www.futuremarketinsights.com/customization-available/rep-gb-13956

Recent Developments

• Pelican BioThermal LLC bought NanoCool Company in February 2020 to expand its line of BioThermal products. After this, the Pelican firm was able to increase its connectivity to last-mile businesses, and laboratories by adding the latter’s customers, and regional market sectors.
• Sonoco ThermoSafe Company debuted their brand-new Pegasus ULD bulk temperature-controlled containers in September 2020. This is a proactive large temperature-controlled container for biopharmaceutical usage in the world and was certified as a unit load device by the FAA. It enables it to move swiftly and inexpensively through current international cargo transportation and customs procedures.
• In June 2020, Softbox introduced Tempcell ECO, which is an innovative curbside recyclable and thermostatic package shipper for the pharmaceutical cold chain market. It makes use of the company’s Thermaflute plastic-free insulating technology and is entirely comprised of corrugated cardboard material.

About Us:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years

Contact Us:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com